Dual functions of PME-1 protein critical for brain development and disease treatment

Dual functions of PME-1 protein critical for brain development and disease treatment

PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some diseases, including Alzheimer's disease (AD) and cancer.

Alzheimer’s Notes: Attitudes towards Alzheimer’s diagnosis and treatment

The Alzheimer’s Association recently released its 2025 Alzheimer’s Disease Facts and Figures report. This report provides an in-depth look at the latest statistics and information on Alzheimer’s disease prevalence, incidence, mortality, dementia care workforce, costs of care and impact on…

LU prof co-leads research to improve dementia care

A Laurentian researcher is collaborating with others to address brain health among aging Indigenous people.

Study suggests promising strategy for decreasing your risk of Alzheimer’s disease

Alzheimer’s disease leads to the deaths of more than 120,000 Americans every year

Scientists find new way to treat Alzheimer’s disease

Researchers at UCLA Health have made a groundbreaking discovery that could change how Alzheimer’s disease is treated. A new molecule called DDL-920 has been found to restore memory and cognitive function in mice with Alzheimer’s-like symptoms. If this success can be repeated in humans, it may lead to a revolutionary way to manage Alzheimer’s disease. […] The post Scientists find new way to treat Alzheimer’s disease appeared first on Knowridge Sc…

Insights on Quanterix Simoa Assay to Diagnose Alzheimer Disease: Mark Roskey, PhD

The chief scientific officer at Quanterix gave a clinical overview on how the company’s Simoa platform enables ultrasensitive detection of neurodegeneration biomarkers in blood, transforming Alzheimer and Parkinson disease research. [WATCH TIME: 3 minutes]